Review



human circrna array v2  (Arraystar inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Arraystar inc human circrna array v2
    Schematic depicting the composition of <t>circRNA_101237</t> (encoded by CDK8). circRNA, circular RNA; CDK8, cyclin-dependent kinase 8; chr, chromosome.
    Human Circrna Array V2, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/circrna+microarray+arraystar+mouse+circrna+array+v2/pmc07092923-163-8-13?v=Arraystar+inc
    Average 90 stars, based on 1 article reviews
    human circrna array v2 - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma"

    Article Title: Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma

    Journal: Experimental and Therapeutic Medicine

    doi: 10.3892/etm.2020.8526

    Schematic depicting the composition of circRNA_101237 (encoded by CDK8). circRNA, circular RNA; CDK8, cyclin-dependent kinase 8; chr, chromosome.
    Figure Legend Snippet: Schematic depicting the composition of circRNA_101237 (encoded by CDK8). circRNA, circular RNA; CDK8, cyclin-dependent kinase 8; chr, chromosome.

    Techniques Used:

    CircRNA_101237 expression in HCC tissues. (A) Heatmap for differentially expressed circRNAs in HCC tumor tissues and the matched adjacent tissues (n=3). (B) RT-qPCR was performed to determine the expression of circRNA_101237 in tumor tissues (n=100) and adjacent tissues (n=100). (C) RT-qPCR was performed to assess the expression of circRNA_101237 in serum samples from patients with HCC (n=234) and healthy controls (n=120). (D) Kaplan-Meier survival curves were drawn to compare the survival of patients with high circRNA_101237 expression (n=148) and those with low circRNA_101237 expression (n=86). RT-qPCR, reverse transcription-quantitative PCR; HCC, hepatocellular carcinoma; circRNA_101237, circular RNA 101237; hsa, Homo sapiens.
    Figure Legend Snippet: CircRNA_101237 expression in HCC tissues. (A) Heatmap for differentially expressed circRNAs in HCC tumor tissues and the matched adjacent tissues (n=3). (B) RT-qPCR was performed to determine the expression of circRNA_101237 in tumor tissues (n=100) and adjacent tissues (n=100). (C) RT-qPCR was performed to assess the expression of circRNA_101237 in serum samples from patients with HCC (n=234) and healthy controls (n=120). (D) Kaplan-Meier survival curves were drawn to compare the survival of patients with high circRNA_101237 expression (n=148) and those with low circRNA_101237 expression (n=86). RT-qPCR, reverse transcription-quantitative PCR; HCC, hepatocellular carcinoma; circRNA_101237, circular RNA 101237; hsa, Homo sapiens.

    Techniques Used: Expressing, Quantitative RT-PCR, Real-time Polymerase Chain Reaction

    Clinical association between serum circRNA_101237 levels and clinicopathological characteristics of patients with hepatocellular carcinoma.
    Figure Legend Snippet: Clinical association between serum circRNA_101237 levels and clinicopathological characteristics of patients with hepatocellular carcinoma.

    Techniques Used: Expressing

    Univariate analysis of prognostic factors for patients with hepatocellular carcinoma.
    Figure Legend Snippet: Univariate analysis of prognostic factors for patients with hepatocellular carcinoma.

    Techniques Used:

    Multivariate analysis of independent prognostic factors for patients with hepatocellular carcinoma.
    Figure Legend Snippet: Multivariate analysis of independent prognostic factors for patients with hepatocellular carcinoma.

    Techniques Used:

    Expression of circRNA_101237 is associated with cisplatin resistance. (A) RT-qPCR was performed to assess the expression of circRNA_101237 in serum samples of patients with cisplatin-sensitive HCC (n=50) and those with cisplatin-resistant HCC (n=35). (B) RT-qPCR was performed to determine the expression of circRNA_101237 in liver cancer cells. * P<0.05 vs. HCCLM3 cells; #P<0.05, Huh7/DDP vs. Huh7. Huh/DDP, cisplatin-resistant Huh7 cells; RT-qPCR, reverse transcription-quantitative PCR; HCC, hepatocellular carcinoma; circRNA_101237, circular RNA 101237.
    Figure Legend Snippet: Expression of circRNA_101237 is associated with cisplatin resistance. (A) RT-qPCR was performed to assess the expression of circRNA_101237 in serum samples of patients with cisplatin-sensitive HCC (n=50) and those with cisplatin-resistant HCC (n=35). (B) RT-qPCR was performed to determine the expression of circRNA_101237 in liver cancer cells. * P<0.05 vs. HCCLM3 cells; #P<0.05, Huh7/DDP vs. Huh7. Huh/DDP, cisplatin-resistant Huh7 cells; RT-qPCR, reverse transcription-quantitative PCR; HCC, hepatocellular carcinoma; circRNA_101237, circular RNA 101237.

    Techniques Used: Expressing, Quantitative RT-PCR, Real-time Polymerase Chain Reaction

    Changes in circRNA_101237 expression in hepatocellular carcinoma cell lines in response to cisplatin treatment. (A) Cells were treated for 48 h with cisplatin at 0, 0.5, 1 and 2 µg/ml. (B) Cells were treated with cisplatin at 1 µg/ml for 0, 12, 24 or 48 h. Reverse transcription-quantitative PCR was performed to assess the expression of circRNA_101237. *P<0.05 vs. controls. circRNA_101237, circular RNA 101237.
    Figure Legend Snippet: Changes in circRNA_101237 expression in hepatocellular carcinoma cell lines in response to cisplatin treatment. (A) Cells were treated for 48 h with cisplatin at 0, 0.5, 1 and 2 µg/ml. (B) Cells were treated with cisplatin at 1 µg/ml for 0, 12, 24 or 48 h. Reverse transcription-quantitative PCR was performed to assess the expression of circRNA_101237. *P<0.05 vs. controls. circRNA_101237, circular RNA 101237.

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction



    Similar Products

    circrna expression microarray slide arraystar mouse circrna array v2 (8 × 15k)  (Arraystar inc)
    90
    Arraystar inc circrna expression microarray slide arraystar mouse circrna array v2 (8 × 15k)
    Characterization of the expression profile of circular RNAs in blood samples of MCAO-treated mice. (A) Normalized intensities of all circular RNAs expressed in the blood in sham and 5 min, 3-h, and 24-h MCAO-treated mice; n = 3 per group. (B) The scatter plots show the differentially expressed circRNAs in the 5-min, 3-h, and 24-h MCAO groups compared with sham. circRNAs in the scatter plot above and below the diagonal line indicate upregulation and downregulation, respectively. (C) Volcano plots show <t>circRNA</t> expression profiles in the 5-min, 3-h, and 24-h MCAO groups compared with sham control. Red dots represent differentially expressed circRNAs ( p < 0.05 and fold-change ≥ 2.0). (D) Distribution of different types of differentially expressed circRNAs, including those consisting of exon, intron, intergenic region, sense, and antisense sequences. (E) Venn diagram shows the overlapping differentially expressed circRNA probes among the three groups compared with sham control. The total numbers of probes exhibiting differential expression in 5 min, 3 h, and 24 h are 1051, 782, and 2721, respectively.
    Circrna Expression Microarray Slide Arraystar Mouse Circrna Array V2 (8 × 15k), supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/circrna+microarray+arraystar+mouse+circrna+array+v2/pmc07015875-65-15-19?v=Arraystar+inc
    Average 90 stars, based on 1 article reviews
    circrna expression microarray slide arraystar mouse circrna array v2 (8 × 15k) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    circrna microarray arraystar mouse circrna array v2  (Arraystar inc)
    90
    Arraystar inc circrna microarray arraystar mouse circrna array v2
    The primers used in qRT-PCR experiments.
    Circrna Microarray Arraystar Mouse Circrna Array V2, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/circrna+microarray+arraystar+mouse+circrna+array+v2/pmc06697070-120-1-6?v=Arraystar+inc
    Average 90 stars, based on 1 article reviews
    circrna microarray arraystar mouse circrna array v2 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Characterization of the expression profile of circular RNAs in blood samples of MCAO-treated mice. (A) Normalized intensities of all circular RNAs expressed in the blood in sham and 5 min, 3-h, and 24-h MCAO-treated mice; n = 3 per group. (B) The scatter plots show the differentially expressed circRNAs in the 5-min, 3-h, and 24-h MCAO groups compared with sham. circRNAs in the scatter plot above and below the diagonal line indicate upregulation and downregulation, respectively. (C) Volcano plots show circRNA expression profiles in the 5-min, 3-h, and 24-h MCAO groups compared with sham control. Red dots represent differentially expressed circRNAs ( p < 0.05 and fold-change ≥ 2.0). (D) Distribution of different types of differentially expressed circRNAs, including those consisting of exon, intron, intergenic region, sense, and antisense sequences. (E) Venn diagram shows the overlapping differentially expressed circRNA probes among the three groups compared with sham control. The total numbers of probes exhibiting differential expression in 5 min, 3 h, and 24 h are 1051, 782, and 2721, respectively.

    Journal: Frontiers in Neuroscience

    Article Title: Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke

    doi: 10.3389/fnins.2020.00081

    Figure Lengend Snippet: Characterization of the expression profile of circular RNAs in blood samples of MCAO-treated mice. (A) Normalized intensities of all circular RNAs expressed in the blood in sham and 5 min, 3-h, and 24-h MCAO-treated mice; n = 3 per group. (B) The scatter plots show the differentially expressed circRNAs in the 5-min, 3-h, and 24-h MCAO groups compared with sham. circRNAs in the scatter plot above and below the diagonal line indicate upregulation and downregulation, respectively. (C) Volcano plots show circRNA expression profiles in the 5-min, 3-h, and 24-h MCAO groups compared with sham control. Red dots represent differentially expressed circRNAs ( p < 0.05 and fold-change ≥ 2.0). (D) Distribution of different types of differentially expressed circRNAs, including those consisting of exon, intron, intergenic region, sense, and antisense sequences. (E) Venn diagram shows the overlapping differentially expressed circRNA probes among the three groups compared with sham control. The total numbers of probes exhibiting differential expression in 5 min, 3 h, and 24 h are 1051, 782, and 2721, respectively.

    Article Snippet: Fifty microliters of hybridization solution was dispensed into the gasket slide and assembled on the circRNA expression microarray slide [Arraystar Mouse circRNA Array v2 (8 × 15K, Arraystar)].

    Techniques: Expressing, Control, Quantitative Proteomics

    RT-qPCR verification of the microarray data from mouse blood. Representative circRNAs with significant differential expression at 5 min (upper panel), 3 h (middle panel), and 24 h of MCAO (lower panel) were verified by RT-qPCR. Left and right panels show the circRNAs with upregulation and downregulation, respectively. Values are mean ± SEM ( n = 3 per group). ∗ p < 0.05, ∗∗ p < 0.05, and ∗∗∗ p < 0.001 compared with sham (independent samples t -test, single-tailed).

    Journal: Frontiers in Neuroscience

    Article Title: Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke

    doi: 10.3389/fnins.2020.00081

    Figure Lengend Snippet: RT-qPCR verification of the microarray data from mouse blood. Representative circRNAs with significant differential expression at 5 min (upper panel), 3 h (middle panel), and 24 h of MCAO (lower panel) were verified by RT-qPCR. Left and right panels show the circRNAs with upregulation and downregulation, respectively. Values are mean ± SEM ( n = 3 per group). ∗ p < 0.05, ∗∗ p < 0.05, and ∗∗∗ p < 0.001 compared with sham (independent samples t -test, single-tailed).

    Article Snippet: Fifty microliters of hybridization solution was dispensed into the gasket slide and assembled on the circRNA expression microarray slide [Arraystar Mouse circRNA Array v2 (8 × 15K, Arraystar)].

    Techniques: Quantitative RT-PCR, Microarray, Quantitative Proteomics

    circRNA-miRNA interaction. Diagrams show the predicted miRNAs (square boxes) that bind to the verified differentially expressed circRNAs (round circles) at the 5-min (A) , 3-h (B) , and 24-h (C) time points of MCAO in mice. Blue lines represent upregulation; red lines represent downregulation.

    Journal: Frontiers in Neuroscience

    Article Title: Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke

    doi: 10.3389/fnins.2020.00081

    Figure Lengend Snippet: circRNA-miRNA interaction. Diagrams show the predicted miRNAs (square boxes) that bind to the verified differentially expressed circRNAs (round circles) at the 5-min (A) , 3-h (B) , and 24-h (C) time points of MCAO in mice. Blue lines represent upregulation; red lines represent downregulation.

    Article Snippet: Fifty microliters of hybridization solution was dispensed into the gasket slide and assembled on the circRNA expression microarray slide [Arraystar Mouse circRNA Array v2 (8 × 15K, Arraystar)].

    Techniques:

    Gene ontology analysis. Gene ontology classifications of the circRNA-miRNA target genes at the (A) 5-min, (B) 3-h, and (C) 24-h time points of MCAO. Color key represents log( p -value).

    Journal: Frontiers in Neuroscience

    Article Title: Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke

    doi: 10.3389/fnins.2020.00081

    Figure Lengend Snippet: Gene ontology analysis. Gene ontology classifications of the circRNA-miRNA target genes at the (A) 5-min, (B) 3-h, and (C) 24-h time points of MCAO. Color key represents log( p -value).

    Article Snippet: Fifty microliters of hybridization solution was dispensed into the gasket slide and assembled on the circRNA expression microarray slide [Arraystar Mouse circRNA Array v2 (8 × 15K, Arraystar)].

    Techniques:

    KEGG pathway analysis of circRNA-miRNA target genes. (A) KEGG pathway analysis of the circRNA-miRNA target genes at the (A) 5-min, (B) 3-h and (C) 24-h time points of MCAO. Color key represents log( p value).

    Journal: Frontiers in Neuroscience

    Article Title: Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke

    doi: 10.3389/fnins.2020.00081

    Figure Lengend Snippet: KEGG pathway analysis of circRNA-miRNA target genes. (A) KEGG pathway analysis of the circRNA-miRNA target genes at the (A) 5-min, (B) 3-h and (C) 24-h time points of MCAO. Color key represents log( p value).

    Article Snippet: Fifty microliters of hybridization solution was dispensed into the gasket slide and assembled on the circRNA expression microarray slide [Arraystar Mouse circRNA Array v2 (8 × 15K, Arraystar)].

    Techniques:

    The primers used in qRT-PCR experiments.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice

    doi: 10.3389/fnmol.2019.00196

    Figure Lengend Snippet: The primers used in qRT-PCR experiments.

    Article Snippet: The circRNA microarray was analyzed using Arraystar Mouse circRNA Array V2 analysis (Arraystar, Inc., United States) by Kangchen BioTech, Inc. (Shanghai, China).

    Techniques:

    Top 10 up- and down-regulated DEcircRNAs in the hippocampus of Nrf2 (−/−) mice.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice

    doi: 10.3389/fnmol.2019.00196

    Figure Lengend Snippet: Top 10 up- and down-regulated DEcircRNAs in the hippocampus of Nrf2 (−/−) mice.

    Article Snippet: The circRNA microarray was analyzed using Arraystar Mouse circRNA Array V2 analysis (Arraystar, Inc., United States) by Kangchen BioTech, Inc. (Shanghai, China).

    Techniques:

    QRT-PCR validation of the expression levels of candidate circRNAs (A) and lncRNAs (B) . * p < 0.05 and ∗∗ p < 0.01. The deep red column indicates the expression status of lncRNAs through microarray analyses; the blue column indicates the expression status of lncRNAs through qRT-PCR experiments. n = 3.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice

    doi: 10.3389/fnmol.2019.00196

    Figure Lengend Snippet: QRT-PCR validation of the expression levels of candidate circRNAs (A) and lncRNAs (B) . * p < 0.05 and ∗∗ p < 0.01. The deep red column indicates the expression status of lncRNAs through microarray analyses; the blue column indicates the expression status of lncRNAs through qRT-PCR experiments. n = 3.

    Article Snippet: The circRNA microarray was analyzed using Arraystar Mouse circRNA Array V2 analysis (Arraystar, Inc., United States) by Kangchen BioTech, Inc. (Shanghai, China).

    Techniques: Quantitative RT-PCR, Biomarker Discovery, Expressing, Microarray

    DEcircRNA-miRNA-DEceRNA interaction subnetworks of up-regulated circRNAs and down-regulated circRNAs in the Nrf2 (–/–) hippocampus. (A) Subnetwork of mmu_circRNA_44531 in the Nrf2 (–/–) hippocampus. (B) Subnetwork of mmu_circRNA_34132 in the Nrf2 (–/–) hippocampus. (C) Subnetwork of mmu_circRNA_000903 in the Nrf2 (–/–) hippocampus. (D) Subnetwork of mmu_circRNA_018676 in the Nrf2 (–/–) hippocampus. (E) Subnetwork of mmu_circRNA_45901 in the Nrf2 (–/–) hippocampus. (F) Subnetwork of mmu_circRNA_33836 in the Nrf2 (–/–) hippocampus. (G) Subnetwork of mmu_circRNA_34137 in the Nrf2 (–/–) hippocampus. (H) Subnetwork of mmu_circRNA_34106 in the Nrf2 (–/–) hippocampus. (I) Subnetwork of mmu_circRNA_008691 in the Nrf2 (–/–) hippocampus. (J) Subnetwork of mmu_circRNA_003237 in the Nrf2 (–/–) hippocampus. Yellow nodes indicate DEcircRNAs. Magenta and green nodes indicate miRNAs sponged by DEcircRNAs and the gene ID of their DEceRNAs, respectively. Edges represent interactions.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice

    doi: 10.3389/fnmol.2019.00196

    Figure Lengend Snippet: DEcircRNA-miRNA-DEceRNA interaction subnetworks of up-regulated circRNAs and down-regulated circRNAs in the Nrf2 (–/–) hippocampus. (A) Subnetwork of mmu_circRNA_44531 in the Nrf2 (–/–) hippocampus. (B) Subnetwork of mmu_circRNA_34132 in the Nrf2 (–/–) hippocampus. (C) Subnetwork of mmu_circRNA_000903 in the Nrf2 (–/–) hippocampus. (D) Subnetwork of mmu_circRNA_018676 in the Nrf2 (–/–) hippocampus. (E) Subnetwork of mmu_circRNA_45901 in the Nrf2 (–/–) hippocampus. (F) Subnetwork of mmu_circRNA_33836 in the Nrf2 (–/–) hippocampus. (G) Subnetwork of mmu_circRNA_34137 in the Nrf2 (–/–) hippocampus. (H) Subnetwork of mmu_circRNA_34106 in the Nrf2 (–/–) hippocampus. (I) Subnetwork of mmu_circRNA_008691 in the Nrf2 (–/–) hippocampus. (J) Subnetwork of mmu_circRNA_003237 in the Nrf2 (–/–) hippocampus. Yellow nodes indicate DEcircRNAs. Magenta and green nodes indicate miRNAs sponged by DEcircRNAs and the gene ID of their DEceRNAs, respectively. Edges represent interactions.

    Article Snippet: The circRNA microarray was analyzed using Arraystar Mouse circRNA Array V2 analysis (Arraystar, Inc., United States) by Kangchen BioTech, Inc. (Shanghai, China).

    Techniques: